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NELSON B. SCHILLER,  MD, FACC, NEAL H. COHEN, MD, ELYSE FOSTER, MD, FACC 
San Francisco, California 
Objectives. This study sought o determine the prognostic yield 
and utility of transesophageal chocardiography in critically ill 
patients with unexplained hypotension. 
Background. Transesophageal echocardiography is increas- 
ingly utilized in the intensive care setting and is particularly 
suited for the evaluation of hypotension; however, the prognostic 
yield of transesophageal chocardiography in these patients is 
unknown. 
Methods. We prospectively studied 61 adult patients in the 
intensive care unit with sustained (>60 rain) unexplained hypo- 
tension. Both transthoracic and transesophageal echocardiogra- 
phy were performed, and results were immediately disclosed to the 
primary physician, who reported any resulting changes in man- 
agement. Patients were classified on the basis of transesophageal 
echocardiographic findings into one of three prognostic groups: 1) 
nonventricular (valvular, pericardial) cardiac limitation to car- 
diac output; 2) ventricular failure; and 3) noncardiac systemic 
disease (hypovolemia or low systemic vascular esistance, or 
both). Primary end points were death or discharge from the 
intensive care unit. 
Results. A transesophageal chocardiographic d agnosis of 
nonventricular limitation to cardiac output was associated with 
improved survival to discharge from the intensive care unit (81%) 
versus a diagnosis of ventricular disease (41%) or hypovolemia/ 
low systemic vascular esistance (44%, p = 0.03). Twenty-nine 
(64%) of 45 transthoracic echocardiographic studies were inade- 
quate compared with 2 (3%) of 61 transesophageal chocardio- 
graphic studies (p < 0.001). Transesophageal chocardiography 
contributed new clinically significant diagnoses (not seen with 
transthoracic e hocardiography) in 17 patients (28%), leading to 
operation in 12 (20%). 
Conclusions. Transesophageal chocardiography makes aclin- 
ically important contribution tothe diagnosis and management of 
unexplained hypotension and predicts prognosis in the critical 
care setting. 
(J Am Coil Cardiol 1995;26:152-8) 
Determining the etiology of hypotension in the critically ill 
patient is essential to a rapid and appropriate therapeutic 
response. The relative contributions of left ventricular systolic 
dysfunction, excessive afterload and inadequate preload are 
often unclear in these patients, even when invasive hemody- 
namic monitoring is utilized. Moreover, structural abnormali- 
ties amenable to surgical intervention may be undiagnosed. 
Recently, echocardiography has been shown to provide valu- 
able information in the critical care setting with regard to 
volume status, contractility and valvular function (1-3). The 
transthoracic approach, although noninvasive, is frequently 
unsatisfactory (4) because of obstacles limiting the acoustic 
window, such as suboptimal patient position and mechanical 
ventilation. These problems are overcome with the use of 
transesophageal echocardiography (5,6). Transesophageal 
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echocardiography hasfound application i the intensive care unit 
for an increasing number of indications, including endocarditis, 
pericardial tamponade, ventricular dysfunction, aortic dissection 
and myocardial rupture (7-10). Several studies have demon- 
strated the utility and safety of transesophageal echocardiography 
in a wide spectrum of critically ill patients (4,10,11). However, the 
prognostic value of transesophageal chocardiography in hypo- 
tensive patients has not been reported. 
In addition, although several retrospective studies have 
demonstrated the improved diagnostic yield of transesoph- 
ageal echocardiography when transthoracic e hocardiography 
was inadequate (2,4,7,9), to our knowledge a prospective 
comparison of transthoracic and transesophageal chocardiog- 
raphy has not been performed in critically ill patients. 
The primary aim of this study was to determine prospec- 
tively the prognostic yield of transesophageal echocardiogra- 
phy in unexplained hypotension. A second objective was to 
compare the diagnostic efficacy of transesophageal and trans- 
thoracic echocardiography in the critical care setting. 
Methods  
Study design. Patients were entered into study by both 
passive and active recruitment. The study group included two 
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groups of patients. First, all hypotensive critically ill patients 
clinically referred for transesophageal chocardiography at the 
University of California San Francisco echocardiography lab- 
oratory over a 14-month period beginning November 1992 
were included. To control for possible selection bias with this 
referred cohort, additional patients were actively recruited 
over a concomitant 6-month period by screening those in 
intensive care units. 
Patients qualified for the study if 1) they were admitted to 
the intensive care unit or cared for in the emergency room; and 
2) they underwent transesophageal chocardiography during a 
sustained unexplained episode of hypotension. The definition 
of sustained unexplained hypotension was either 1) a systolic 
blood pressure decrease from a stable baseline level (>4 h) 
>20%, with an absolute systolic pressure <100 mm Hg; or 2) 
an intravenous vasopressor requirement for >60 rain in the 
setting of uncertain contractility or loading conditions. Exclu- 
sion criteria were 1) massive gastrointestinal b eeding, 2) 
documented end-stage cardiomyopathy, 3) routine vasopressor 
support in the postcardiothoracic surgical patient, and 4) age 
<18 years. The indication for the study, transesophageal 
echocardiographic and transthoracic echocardiographic re- 
sults, final diagnosis, patient demographics and any transesoph- 
ageal echocardiographic complications were recorded. 
During the 14-month study period, a total of 323 patients 
were referred for transesophageal echocardiography at the 
University of California San Francisco echocardiography lab- 
oratory. Forty-four of these patients (14%) had unexplained 
hypotension at the time of transesophageal chocardiography 
and qualified for the study. 
During the 6-month period of active recruitment, he four 
intensive care units (coronary care unit, medical-surgical in- 
tensive care unit, cardiothoracic surgical intensive care unit 
and neurologic/neurosurgical intensive care unit; total 46 beds) 
of a 560-bed university medical center were screened aily for 
patients with unexplained hypotension. Each patient's chart 
was examined for evidence of hypotension and for diagnosis. A
total of 3,903 charts were reviewed from 1,361 patients, and 
351 hypotensive episodes were documented. There were 105 
hypotensive episodes in 101 patients that fulfilled the criteria 
for unexplained hypotension. Of these 101 patients, 17 (17%) 
were actively recruited, and another 18 were referred for 
transesophageal chocardiography b  their primary physician 
for clinical indications. The remaining patients were not en- 
rolled because of 1) primary physician unwillingness (40%); 2) 
contraindication to transesophageal chocardiography (34%), 
including recent esophageal surgery (1%), thrombocytopenia 
(1%), esophageal b eeding (10%) or concern that transesoph- 
ageal echocardiography would require tracheal intubation to 
be performed safely (9%); 3) resolution of hypotension before 
consent was obtained (22%); or 4) patient or family unwilling- 
ness (4%). The patients recruited by both routes were found to 
be similar (Table 1) and were combined to form the final study 
cohort of 61 patients. (The power to detect a 5- and 10-year 
difference in age between the two patient groups [Table 1] at 
p = 0.05 was 0.64 and 0.99, respectively). All patients or 
Table 1. Clinical Characteristics of Patients Referred for 
Transesophageal Echocardiography and Patients Actively Recruited 
Active 
Referral Recruitment 
(n - 44) (n = 17) p Value 
Age (yr) 63 + 16 66 -+ 18 0.6 
Male (%) 53 53 0.9 
lntubated (%) 95 88 0.7 
PA catheter (%) 47 23 0.2 
Vasopressors (%) 92 76 0.3 
Data presented are mean value _+ SD or percent of patients. PA - 
pulmonary artery. 
appropriate family members and primary physicians provided 
written informed consent for the procedure as approved by the 
Committee on Human Research at the University of California 
San Francisco. 
Echocardiography. Transesophageal echocardiography 
was performed using commercially available ultrasound scan- 
ners (HP Sonos 1000, 1500, multiplane, biplane, pediatric 
transesophageal chocardiographic probes; Acuson XP128 bi- 
plane transesophageal echocardiographic probe; Biosound 
wide-angle monoplane, 3000-AP) equipped with color and 
spectral Doppler. A 5-MHz multiplane phased-array probe 
was used in 43 studies (70%), a biplane phased-array probe in 
13 (21%), a monoplane wide-angle probe in 3 (5%) and a 
7-MHz pediatric biplane probe in 2 (3%). Heart rate, cardiac 
rhythm and pulse oximetry were monitored continuously, and 
blood pressure was measured at least every 3 min. Nonintu- 
bated patients received supplemental oxygen during the pro- 
cedure. If possible, patients were placed in the partial left 
decubitus position for the duration of the study. After topical 
oropharyngeal nesthesia with 1% lidocaine spray, patients 
were sedated as needed using a combination of midazolam and 
fentanyl or morphine. Nasogastric tubes were removed if they 
interfered with esophageal intubation or imaging. Laryngo- 
scopic guidance was employed as needed. Two-dimensional 
imaging of all cardiac chambers, atrial appendages and the 
ascending and descending aorta was performed using standard 
transesophageal and transgastric views (12). Color and pulsed- 
and continuous-wave Doppler evaluation was performed for 
all valves, left and right upper pulmonary veins and the aorta. 
Transthoracic maging was performed with the same ultra- 
sound system as that used for transesophageal imaging, with a 
phased-array transducer f equency selected for optimal image 
quality. An attempt was made to perform transesophageal and 
transthoracic e hocardiography consecutively in all cases; how- 
ever, this was not always possible because of logistic or 
personnel limitations. In 16 of 61 patients, hypotension had 
resolved by the time that transthoracic e hocardiography could 
be performed, and these patients were excluded from the 
transthoracic versus transesophageal chocardiographic com- 
parison. Standard parasternal long-axis, short-axis, apical four- 
chamber and subcostal two dimensional views were obtained. 
M-mode imaging was performed in the parasternal long-axis 
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view. Color and pulsed- and continuous-wave Doppler 
(1.9 MHz) were used to evaluate all valvular structures and 
other areas of high velocity flow. All echocardiographic data 
were recorded on 1/2-in. SVHS videotape. 
The echocardiographic studies were interpreted by experi- 
enced echocardiographers who had no knowledgc of the 
clinical information. The adequacy ofthe examination and new 
diagnostic findings were recorded for both transthoracic and 
transesophagea[ echocardiography. Criteria for examination 
adequacy included visualization of all four cardiac chambers 
and the mitral, aortic and tricuspid valves. All transesophageal 
echocardiographic diagnoses were determined qualitatively by 
experienced echocardiographers. 
Prognostic groups. The patients werc grouped according 
to the mechanism of hypotension on the basis of transesoph- 
ageal echocardiographic f ndings, as follows: group 1 = non- 
ventricular cardiac limitation in cardiac output (e.g., pericar- 
dial or valvular disease); group 2 : depressed ventricular 
systolic function; group 3 = noncardiac/systemic disease; hy- 
povolemia (small cardiac chambers) or low systemic vascular 
resistance (normal to hyperdynamic left ventricular function in 
the setting of hypotension). Patients were grouped by first 
determining the presence or absence of pericardial constraint, 
severe obstruction to flow or severe valvular egurgitation. If
any of thesc findings were prescnt, the patient was placed in 
group 1. The left and right ventricular function were then 
examined, and if either were at least moderately reduced, then 
the patient was placed in group 2. The rcmaining patients were 
assigned to group 3. All group 3 patients had evidence of 
hypovolemia or low systemic vascular esistance. 
Fallow-up. Immediately after transesophageal echocardi- 
ography, the primary physician was contacted, and the echo- 
cardiographic results were communicated. The primary' physi- 
cian was then questioned regarding changes in management, 
including surgical intervention, changcs in volume or vasoprcs- 
sor management, and postponement of planned right heart 
catheterization, that were based on the transesophageal cho- 
cardiographic results. Survival to discharge from the intensive 
care unit and total intensive care unit charges werc recorded. 
Statistical analysis. Proportional data were compared us- 
ing chi-square analysis. When two proportions were compared, 
the chi-square with Yates correction lot continuity was used. 
For 2 × 2 tables with expected cell frequencies <5, the Fisher 
exact est was utilized. An unpaired Student t test was used to 
assess differences in continuous wtriables between two groups. 
To determine the strength of association bctween the trans- 
esophageal echoeardiographic prognostic lass and survival, 
this and other clinical variables were entercd into a stepwise 
multiple logistic regression model (SAS Institute). The Wald 
chi-square statistic derived from the logistic model was used to 
determine whether the transesophageal echocardiographic 
prognostic lass variable remained significantly associated (p < 
0.05) with survival. All results represent mean value ± SD or 
a proportion of the sample size; p < 0.05 was considered 
statistically significant. 
Table 2. Clinical Characteristics of Critically Ill Patients 
With Unexplained Hypotension With and Without 
Yransesophageal Echocardiography 
Transesophageal No Transesophageal 
Echocardiography Echocardiography p 
(n - 61) (n = 69) Value 
Age (yr) 64 + 17 57 ± 16 0.2 
Male (%) 53 58 0.6 
lntubation (%) 93 86 0.2 
PA catheter (5/,) 38 29 0.2 
Vasopressors (%) 89 74 0.1 
ICU mortality 48 52 0.8 
rate ((:~'; )
Data presented are mean value ± SD or percent of patients. 1CU = intensive 
care unit: PA pulmona U artery. 
Resu l ts  
Patient characteristics. During the 14-month study period, 
a total of 61 patients underwent transesophageal chocardiog- 
raphy (mean [+SD] age 64 ± 17 years, range 20 to 93; 53% 
male). At the time of transesophageal chocardiography, 93% 
of patients had mechanical ventilation, 89% were receiving 
intravenous vasopressor medication, and 38% were monitored 
with a pulmonary artery catheter. The intensive care unit 
mortality rate for all patients undergoing transesophageal 
echocardiography, was 48%. These characteristics were similar 
to those of other patients with unexplained hypotension who 
qualified but were not entered into the study (Table 2). The 
most common indication in the patients referred for trans- 
csophagea[ echocardiography was evaluation of valvular or 
pericardial disease (Table 3). 
Transthoracic versus transesophageal echocardiography. 
Forty-five patients (74%) had concurrent transthoracic e ho- 
cardiography. Transthoracic echocardiography provided ade- 
quate visualization of cardiac structures in only 36% of pa- 
tients versus 97% for transesophageal chocardiography (p < 
0.001). All abnormalities observed with transthoracic e hocar- 
diography were observed with transesophageal chocardiogra- 
phy, whereas transesophageal echocardiography provided 17 
Table 3. Indications for 44 Patients Referred for 
Transesophagcal Echocardiography 
No. (%) 
Indication of Pts 95% CI 
Mitral regurgitation 7 (16) 7-30 
Endocarditis 7 (16) 7-30 
Pcricardial disease 6 (14) 5-27 
Pulmona~' embolus 5 (11) 4-25 
Unexplained hypotension 4 (9) 3-22 
Itypotension after myocardial infarction 3 (7) 1-19 
Right vcntricular dysfunction 3 (7) 1-19 
Atrial thrombus 2 (5) 1-16 
Right-toqeft shunt 2 (5) 1-16 
Prosthetic valve function 2 (5) 1-16 
Other 3 (7) 1-19 
C1 '45% confidence interval; Pts - patients. 
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Table 4. Unexpected Findings Observed With 
Transesophageal Echocardiography 
No. (%) 
Unexpected Finding of Pts 95% CI 
Pericardial tamponade 4 (7) 2 16 
Right ventricular failure 4 (7) 2-16 
Severe mitral regurgitation 2 (3) 0- l l  
Right atrial thrombus/embolus 2 (3) 0-11 
Left ventricular outflow obstruction 1 (2) [I-9 
Aortic valve disease 1 (2) 0 9 
Right-to-left shunt 1 (2) 0-9 
Endocarditis 1(2) 0-9 
Wall motion abnormality I (2) 0-9 
Abbreviations as in Table 3. 
new diagnoses (28%) not observed with transthoracic e hocar- 
diography (Table 4). Of the 17 new transesophageal echocar- 
diographic diagnoses, 11 were most likely to have contributed 
directly to the patients' hypotension: pericardial tamponade 
(n = 4), right ventricular failure (n --- 4), mitral regurgitation 
(n = 2), left ventricular outflow obstruction (n = 1). 
Clinical et~cacy. After the communication of transesoph- 
ageal echocardiography results to the primary physician, im- 
mediate changes in management occurred in 48% of patients, 
leading to an improvement in blood pressure in 24%. These 
changes included fluid administration ( = 15), operation (n = 
12), change in vasopressor (n = 5) (Fig. 1), nonsurgical 
invasive procedure (n - 3) and cancellation of scheduled 
invasive procedure (n = 2). The 12 surgical indications were 
ischemic mitral regurgitation (n = 2) (Fig. 2), pericardial 
hematoma (n = 5), right atrial mass (n - 1) (Fig. 3), embolus 
in transit (n = 1) and prosthetic valve dysfunction (n - 3). 
Invasive hemodynamic monitoring with a pulmonary artery 
catheter was ongoing during transesophageal echocardiogra- 
phy in 23 (38%) of 61 patients. In general there was agreement 
between catheterization and transesophageal echocardio- 
graphic results. Patients with a transesophageal echocardio- 
graphic diagnosis of hypovolemia had a lower mean right atrial 
pressure (7 ± 2 mm Hg) than those with depressed left 
ventricular function (18 - 8 mm Hg) or nonventricular cardiac 
limitation in cardiac output (16 ± 7 mm Hg, p = 0.05). In 
addition, patients with a transesophageal echocardiographic 
diagnosis of low systemic vascular esistancc as the cause of 
hypotension had a lower measured value (680 _+ 126 
dynes.s-cm 5) than those with depressed ventricular function 
(1,040 + 556 dynes.s,cm-5) nonventricular cardiac limitation 
in cardiac output (1,090 ± 270 dynes.s.cm 5), although this did 
not reach statistical significance (p = 0.5). 
In patients with a measured low systemic wtscular esistance 
(<800 dynes.s.cm 5), three (50%) of six had depressed vcn- 
tricular function by transesophageal echocardiography that 
was not expected from the catheterization data (pulmonary 
capillary wedge pressure <18 mm Hg, cardiac output >4 
liters/rain). 
Immediate changes in management tended to be more 
Figure 1. Transesophageal choeardiographic image from a 68-year 
old man with opportunistic pneumonia because of immunosuppression 
with steroids for chronic lung disease. Progressive hypotension unre- 
sponsive to dobutamine developed, and after transthoracic e hocardi- 
ography that demonstrated hypovolemia, transesophageal chocardi- 
ography was performed. Systolic anterior motion of the mitral valve 
(MV) obstructing the left ventricular outflow tract (LVOT) is seen. 
After a change of medication from dobutamine toa pure alpha-agonist 
(phenylephrine), systolic blood pressure improved from 50 to 
1 Ill mm Hg. LV = left ventricle; RV = right ventricle. Semicircular 
object next to the left atrium is artifact from the edge of a wide-angle 
270 ° transducer. 
common in patients monitored with than without a pulmonary 
artery catheter (63% vs. 43%, p = 0.2). Management changes 
included a change in vasopressor in 4 (17%) of 23 patients and 
a change in volume administration i  8 (35%) of 23. The 
rationale for these management changes was unsuspected 
ventricular dysfunction (n = 5) or nonventricular limitation in 
cardiac output (n = 5). No changes in management were made 
after a transesophageal echocardiographic diagnosis of hypo- 
volemia or depressed systemic vascular esistance in the group 
with monitoring by pulmonary artery catheter. 
Etiology and prognosis. Ventricular dysfunction and de- 
pressed systemic vascular resistance were the predominant 
causes of hypotension determined by transesophageal chocar- 
diography (Table 5). Patients with a nonventricular cardiac 
limitation of cardiac output had a significantly improved 
survival rate (81%) than those with reduced ventricular func- 
tion (41%) and reduced systemic vascular esistance or hypo- 
volcmia (44%, p = 0.03) as a cause of hypotension (Table 6). 
The transesophageal echocardiographic prognostic lassifica- 
tion remained an independent predictor of mortality (p = 
0.05) after it was combined with age, gender and recent 
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Figure 2. Transesophageal echocardiographic image 
from an 80-year old woman presenting with an acute 
myocardial infarction and cardiogenic shock. A rup- 
tured papillary muscle (P) is demonstrated in mid- 
diastole. Transthoracic echocardiography demon- 
strated mitral regurgitation but not the ruptured 
papillary muscle. LV = left ventricle; LA = left 
atrium. 
7.- 
operation in a multivariablc (logistic regression) model of 
intensive care unit survival. 
To determine differences in intensive care resources con- 
sumed, the hospital bills of each patient were examined. 
Although differences in intensive care unit charges among the 
three prognostic groups existed, they did not reach statistical 
significance (Table 6). 
Safety. The transesophageal echocardiographic probe was 
passed successfully in all 61 patients. In the majority of patients 
the probe was placed blindly. In 4 of 57 mechanically ventilated 
patients, initial attempts at esophageal intubation were unsuc- 
cessful, and laryngoscopic guidance was required to pass the 
transesophageal chocardiographic probe. Sedatives were used 
Figure 3. Transesophageal echocardiographic image from a 45-year 
old man with hypotension and elevated jugular venous pressure several 
days after cardiac transplantation. A mass in the right atrium (RA) is 
demonstrated. Previous transthoracic echocardiography was of poor 
quality, and the cause of high jugular venous pressure was not evident. 
At operation a large atrial septal hematoma bulging into the right 
atrium was evacuated. LA = left atrium; RV = right ventricle. 
in 78% of patients, and paralyzing agents (vecuronium) in 8%. 
The most common sedating medications used were midazolam 
(44% of patients, dose 2.3 -+ 1.8 mg intravenously) and 
fentanyl (28% of patients, dose 74 _+ 34 /zg intravenously). 
Despite the frequent use of sedatives, further decreases in 
blood pressure were minimal. Only one patient had a decrease 
in systolic blood pressure >15%, which responded rapidly to 
volume administration. 
There were two patients with dysrhythmias temporally 
related to the performance of transesophageal echocardiogra- 
phy. In one patient atrial fibrillation occurred during initial 
attempts at intubation. After medical treatment the patient's 
rhythm returned to sinus, and the study was performed 24 h 
later without complication. In a second patient atrial flutter 
developed after 10 rain of imaging and resolved spontaneously. 
Discussion 
Prognosis. The etiology of hypotension as determined by 
transesophageal chocardiography was a predictor of intensive 
care unit mortality in the present study. Patients with nonven- 
tricular cardiac limitations in cardiac output had significantly 
improved survival compared with those with ventricular dys- 
Table 5. Etiology of Hypotension Determined by 
Transesophageal Echocardiography 
No. (%) 
Etiology of Hypotension of Pts 95% CI 
Left ventricular systolic failure 16 (26) 16-40 
Low systemic vascular resistance 13 (21) 12-34 
Right ventricular systolic failure 11 (18) 9-30 
Pericardial compression 8 (13) 6-24 
Hypovolemia 5 (8) 3-18 
Severe mitral regurgitation 4 (7) 2-16 
Left ventricular outflow obstruction 2 (3) 0-11 
Other obstruction toflow 2 (3) 0-11 
Abbreviations a  in Table 3. 
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Table 6. Comparison ofStudy Groups According to 
Transesophageal Echocardiographic Prognosis 
Group 1 Group 2 Group 3 p 
(n - 16) (n - 27) (n 18) Value 
Age (yr) 64 + 13 66 + 16 60 + 21 0.5 
Male (%) 6(1 44 56 0.5 
Recent operation (%) 44 35 33 0.8 
Change in management (%) 75 41 33 0.03 
Operation planned (%) 56 7 6 0.0001 
Mortality rate (%) 19 59 56 0.03 
ICU charge ($1,000) 26 ± 27 42 + 54 60 + 106 0.6 
Data presented are mean value + SD or percent of patients. Group 1 
nonventricular limitation to cardiac output (e.g., valvular, pericardial disease); 
Group 2 = depressed left ventricular or right ventricular contractility; Group 3 
depressed systemic vascular resistance or hypovolcmia, or both: ICU = intensive 
care unit. 
function, hypovolemia or reduced systemic vascular esistance. 
Changes in management after transesophageal chocardiogra- 
phy were also significantly more frequent in this group, and 
these changes may have contributed to the improved survival 
(e.g., valve replacement, removal of pericardial fluid). These 
results are not unexpected. Previous studies have demon- 
strated improved survival in patients with hypotension compli- 
cating acute myocardial infarction secondary, to surgically 
correctable mitral regurgitation versus patients with hypoten- 
sion from ventricular failure (13,14). 
Etficacy. Previous retrospective studies (1-4,8) have dem- 
onstrated the utility of transesophageal echocardiography in 
the intensive care unit in a mixed patient population. The 
present prospective investigation demonstrates a similar high 
yield of clinically useful data in the selected cohort of critically 
ill patients with unexplained hypotension. Of the 61 hypoten- 
sive patients who underwent transesophageal echocardiogra- 
phy, unexpected findings not observed with transesophageaI 
echocardiography were noted in 28%. These findings led to 
operation or cancellation of catheterization i a significant 
number of patients. Less invasive changes in management 
(volume or pressor change) were noted even more frequently. 
Overall, -50% of the patients studied had a change in 
management after transesophageal chocardiography. 
Unexplained hypotension is frequently evaluated using 
invasive hemodynamic monitoring, including pulmonary artery 
catheterization. I  the present study changes in management 
were seen with similar frequency in patients with and without 
pulmonary artery catheterization. These changes were evoked 
primarily by unexpected ventricular dysfunction or nonven- 
tricular limitation in cardiac output. This suggests that trans- 
esophageal echocardiography is additive to invasive hemody- 
namic monitoring in the evaluation of hypotension. Now that 
data are available suggesting improved survival in postopera- 
tive patients using cardiac output as a guide to therapy (15), a 
comparative trial of transesophagcal cchocardiography and 
invasive hemodynamic monitoring to guide therapy should be 
considered. 
Although changes in management were observed after 
transesophageal chocardiography, no difference in survival to 
intensive care unit discharge was detected between study 
patients and those eligible but not undergoing transesophageal 
echocardiography. However, it is still possible that transesoph- 
ageal echocardiography ad a clinically significant impact on 
survival in this patient population. 1) The ability to demon- 
strate a survival advantage for a diagnostic test is difficult 
because of physician differences in response to a given test 
result. 2) This investigation was relatively small in size and, 
more important, nonrandomized. To detect an impact of 
transesophageal chocardiography on survival, a much larger 
randomized trial would be required. 
Transthoraeie versus transesophageal echocardiography. 
Transthoracic echocardiography, although portable and inex- 
pensive, often provides limited information in critically ill 
patients because of technical difficulties. Frequently, patients 
are mechanically ventilated with a limited acoustic window, 
or they cannot be positioned optimally for transthoracic imag- 
ing. Previous investigations of transesophageal chocardiogra- 
phy in critical care patients have noted poor quality trans- 
thoracic images in the intensive care unit setting (2,4,9). The 
present study, designed to prospectively compare transesoph- 
ageal with transthoracic echocardiography, found trans- 
thoracic echocardiography to be of limited value in critically ill 
hypotcnsive patients. Only 36% of the transthoracic echocar- 
diographic evaluations were adequate as determined by a 
blinded reviewer, compared with 97% of transesophageal 
echocardiographic studies. In particular, although depressed 
left ventricular function was noted with both transthoracic and 
transcsophageal chocardiography, significant right ventricular 
dysfunction was noticed only on transesophageal chocardiog- 
raphy in several patients. This finding may have important 
clinical implications for diagnosis and management i  critically 
ill patients with unexplained hypotension (16). 
Safety. The present study demonstrates the safety of trans- 
esophageal echocardiography in a large number of critically ill 
patients with unexplained hypotension. Although the safety of 
transesophageal chocardiography as been demonstrated in 
the intensive care unit setting (4,11), previous tudies have not 
focused on hypotensive patients in whom the risk may be 
increased. Despite the severity of illness, transesophageal 
echocardiography was well tolerated in the present study. Only 
three minor complications occurred, which is equivalent to the 
complication rate for patients in intensive care in general (2) 
and is only slightly above that (0.5% to 1%) for non-critically 
ill patients (17-19). 
Study limitations. The present investigation has several 
potential imitations. A minority (35%) of the hypotensive 
patients in intensive care who were screened actually entered 
the study. If a larger proportion of hypotensive patients had 
been recruited, the efficacy of transesophageal chocardiogra- 
phy in this cohort would be known with greater accuracy. The 
definition of unexplained hypotension i the present study was 
purposely not restrictive so as to include as many types of 
hypotensive patients as possible. The applicability of our data, 
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therefore, to any specific subgroup of hypotensive patients is 
less clear and requires further investigation. 
The reproducibility of the study results may be limited by 
the use of qualitative diagnostic riteria for the etiology of 
hypotension. Unfortunately, accurate methods for quantifica- 
tion of valvular and ventricular function are not established for 
transesophageal chocardiography at this time. 
The interpretation of the echocardiograms could not be 
blinded to the type of echocardiographic study (transthoracic 
vs. transesophageal). Although a bias favoring transesophageal 
echocardiography cannot be excluded, the substantial differ- 
ences between transthoracic and transesophageal chocardio- 
graphic quality in our study argue that the two techniques are 
not of equal clinical value in this patient cohort. 
Because of the nonrandomized design of the study, the 
effect of transesophageal echocardiography on the mortality 
rate and costs is unclear and requires further investigation. 
Conclusions. In a group of critically ill hypotensive pa- 
tients, transesophageal chocardiography was successfully per- 
formed in all patients and posed minimal risk. Transthoracic 
echocardiography was inadequate in a high proportion of 
patients, whereas transesophageal echocardiography fre- 
quently resulted in new diagnoses not observed with trans- 
thoracic echocardiography. This information prompted 
changes in clinical management, including operation and cath- 
eterization. A transesophageal chocardiographic d agnosis of 
a nonventricular limitation in cardiac output was associated 
with a significantly improved survival rate compared with a 
diagnosis of ventricular dysfunction or reduced systemic vas- 
cular resistance. Transesophageal chocardiography should be 
strongly considered in the evaluation of the critically ill patient 
with unexplained hypotension. 
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